These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

541 related items for PubMed ID: 34408988

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Caffeic acid phenethyl ester synergistically enhances the antifungal activity of fluconazole against resistant Candida albicans.
    Sun L, Liao K, Hang C.
    Phytomedicine; 2018 Feb 01; 40():55-58. PubMed ID: 29496175
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Temporal Profile of Biofilm Formation, Gene Expression and Virulence Analysis in Candida albicans Strains.
    de Barros PP, Rossoni RD, De Camargo Ribeiro F, Junqueira JC, Jorge AO.
    Mycopathologia; 2017 Apr 01; 182(3-4):285-295. PubMed ID: 27830437
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Caffeic Acid Phenethyl Ester (CAPE) Inhibits Cross-Kingdom Biofilm Formation of Streptococcus mutans and Candida albicans.
    Yin W, Zhang Z, Shuai X, Zhou X, Yin D.
    Microbiol Spectr; 2022 Oct 26; 10(5):e0157822. PubMed ID: 35980199
    [Abstract] [Full Text] [Related]

  • 9. Antifungal Activity of the Phenolic Compounds Ellagic Acid (EA) and Caffeic Acid Phenethyl Ester (CAPE) against Drug-Resistant Candida auris.
    Possamai Rossatto FC, Tharmalingam N, Escobar IE, d'Azevedo PA, Zimmer KR, Mylonakis E.
    J Fungi (Basel); 2021 Sep 15; 7(9):. PubMed ID: 34575801
    [Abstract] [Full Text] [Related]

  • 10. Development of Anti-Virulence Approaches for Candidiasis via a Novel Series of Small-Molecule Inhibitors of Candida albicans Filamentation.
    Romo JA, Pierce CG, Chaturvedi AK, Lazzell AL, McHardy SF, Saville SP, Lopez-Ribot JL.
    mBio; 2017 Dec 05; 8(6):. PubMed ID: 29208749
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. In Vitro and In Vivo Antifungal Activity of Lichochalcone-A against Candida albicans Biofilms.
    Seleem D, Benso B, Noguti J, Pardi V, Murata RM.
    PLoS One; 2016 Dec 05; 11(6):e0157188. PubMed ID: 27284694
    [Abstract] [Full Text] [Related]

  • 14. Candida tropicalis affects the virulence profile of Candida albicans: an in vitro and in vivo study.
    de Barros PP, Rossoni RD, Freire F, Ribeiro FC, Lopes LADC, Junqueira JC, Jorge AOC.
    Pathog Dis; 2018 Mar 01; 76(2):. PubMed ID: 29617858
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Gellan-Based Hydrogel as a Drug Delivery System for Caffeic Acid Phenethyl Ester in the Treatment of Oral Candida albicans Infections.
    Garcia MT, Carmo PHFD, Figueiredo-Godoi LMA, Gonçalves NI, Lima PMN, Ramos LP, Oliveira LD, Borges ALS, Shukla A, Junqueira JC.
    Pharmaceutics; 2024 Feb 20; 16(3):. PubMed ID: 38543192
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Riboflavin Targets the Cellular Metabolic and Ribosomal Pathways of Candida albicans In Vitro and Exhibits Efficacy against Oropharyngeal Candidiasis.
    Lei J, Huang J, Xin C, Liu F, Zhang J, Xie Y, Mao Y, Chen W, Song Z.
    Microbiol Spectr; 2023 Feb 14; 11(1):e0380122. PubMed ID: 36625571
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 28.